Skip to content

Magnitude of Osteoarthritis disadVantage on pEoples liveS

Magnitude of Osteoarthritis disadVantage on pEoples liveS

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01423097
Acronym
MOVES
Enrollment
1015
Registered
2011-08-25
Start date
2011-09-30
Completion date
2011-11-30
Last updated
2012-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

osteoarthritis symptoms

Brief summary

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age: * Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain) * Characterization of OA diagnosis in patients with self-reported OA * Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0) * Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA * Patient perception of impact of OA in its life and importance given to disease

Detailed description

Magnitude of Osteoarthritis disadvantage on peoples lives.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Adults over 45 years old with self-reported osteoarthritis

Exclusion criteria

\- NA

Design outcomes

Primary

MeasureTime frame
Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.Single interview at the only one patient contact

Secondary

MeasureTime frame
Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.Single interview at the only one patient contact
Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0Single interview at the only one patient contact
Patient perception of impact of OA in its life and importance given to disease by direct interview.Single interview at the only one patient contact
Characterization of OA diagnosis in patients with self-reported OA by direct interview.Single interview at the only one patient contact

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026